Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Mangoceuticals (MGRX) Revenue (2023 - 2025)

Mangoceuticals' Revenue history spans 3 years, with the latest figure at $94360.0 for Q4 2025.

  • On a quarterly basis, Revenue fell 10.34% to $94360.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $456021.0, a 25.96% decrease, with the full-year FY2025 number at $456021.0, down 25.96% from a year prior.
  • Revenue hit $94360.0 in Q4 2025 for Mangoceuticals, up from $84246.0 in the prior quarter.
  • Over the last five years, Revenue for MGRX hit a ceiling of $245160.0 in Q3 2023 and a floor of $84246.0 in Q3 2025.
  • Historically, Revenue has averaged $150282.2 across 3 years, with a median of $137302.5 in 2023.
  • The widest YoY moves for Revenue: up 112.56% in 2024, down 56.93% in 2024.
  • Tracing MGRX's Revenue over 3 years: stood at $244374.0 in 2023, then plummeted by 56.93% to $105247.0 in 2024, then dropped by 10.34% to $94360.0 in 2025.
  • Business Quant data shows Revenue for MGRX at $94360.0 in Q4 2025, $84246.0 in Q3 2025, and $168109.0 in Q2 2025.